Francesca Ruscitti

Gabriella Bergamini^*,1, 

Fabio Stellari^*,2, 

Angela Sandri^*,3, 

Maria M. Lleo³, 

Gaetano Donofrio⁴, 

Francesca Ruscitti^5,2, 

Federico Boschi⁶, 

Andrea Sbarbati⁷, 

Gino Villetti², 

Paola Melotti⁸, 

Claudio Sorio¹ 

¹Department of Medicine, General Pathology Division, Cystic Fibrosis Translational Research Laboratory "D. Lissandrini", University of Verona, 

²Corporate Preclinical R&D, Chiesi Farmaceutici S.p.A., 

³Department of Diagnostic and Public Health, Microbiology Division, University of Verona, 

⁴Dipartimento di Scienze Medico-Veterinarie, University of Parma, 

⁵Department of Biomedical Biotechnological and Translational Sciences, University of Parma, 

⁶Department of Computer Science, University of Verona, 

⁷Department of Neurological, Biomedical and Movement Sciences, University of Verona, 

⁸Cystic Fibrosis Regional Center (CFC), AOUI Verona 

Francesca Ruscitti¹, 

Francesca Ravanetti², 

Gaetano Donofrio², 

Yanto Ridwan³, 

Paula van Heijningen³, 

Jeroen Essers⁴, 

Gino Villetti¹, 

Antonio Cacchioli², 

Wim Vos⁵, 

Franco Fabio Stellari¹ 

¹Corporate Preclinical R&D, Chiesi Farmaceutici S.p.A., 

²Department of Veterinary Science, University of Parma, 

³Department of Molecular Genetics, Erasmus MC, 

⁴Department of Molecular Genetics, Vascular Surgery, Radiation Oncology, Erasmus MC, 

⁵, Fluidda NV